CD8A and cancer: The cross-talk of TAMs with cancer cells, liver sinusoid endothelial cells (LSECs), CAFs, and other immune cells types including neutrophils, Tregs, NKs, and CD8+ T lymphocytes supports angiogenesis, fibrosis, immunosuppression, and ultimately, promotion of cancer growth and metastasis (Figure 2).